DUBLIN–(BUSINESS WIRE)–The “Stem Cell Therapy Market: Trends, Opportunities and Competitive Analysis 2023-2028” report has been added to ResearchAndMarkets.com’s offering.
The global stem cell therapy market is projected to achieve an estimated value of $0.9 billion by 2028, exhibiting a remarkable Compound Annual Growth Rate (CAGR) of 14.7% from 2023 to 2028.
The market’s major driving factors include the rising number of cell therapy production facilities, a surge in clinical trials associated with stem cell therapies, and robust government funding for stem cell research.
This report delves into the promising future of the global stem cell therapy market, identifying lucrative opportunities in various applications, including musculoskeletal disorders, wound & injury treatment, cardiovascular disease management, surgery support, inflammatory & autoimmune disease treatment, and neurological disorder therapies.
Stem Cell Therapy Market Segmentation:
The comprehensive study encompasses trends and forecasts for the global stem cell therapy market across multiple segments, including type, cell source, application, and region:
Stem Cell Therapy Market by Type:
- Allogeneic Stem Cell Therapy
- Autologous Stem Cell Therapy
Stem Cell Therapy Market by Cell Source:
- Adipose Tissue-Derived MSCs (Mesenchymal Stem Cells)
- Bone Marrow-Derived MSCs
- Placental/Umbilical Cord-Derived MSCs
- Others
Stem Cell Therapy Market by Application:
- Musculoskeletal Disorders
- Wounds & Injuries
- Cardiovascular Diseases
- Surgeries
- Inflammatory & Autoimmune Diseases
- Neurological Disorders
- Others
Stem Cell Therapy Market by Region:
- North America
- Europe
- Asia Pacific
- The Rest of the World
List of Key Stem Cell Therapy Companies:
In this competitive market, companies vie for supremacy based on the quality of their offerings. Major players in the stem cell therapy market are dedicated to expanding their manufacturing facilities, making R&D investments, developing infrastructures, and leveraging integration opportunities across the value chain. These strategies empower stem cell therapy companies to cater to the rising demand, maintain competitive effectiveness, drive product and technological innovation, reduce production costs, and expand their customer base.
Some of the key stem cell therapy companies, as profiled in this report, include:
- Smith+Nephew
- Medipost
- Anterogen
- Pharmicell
- NuVasive
- JCR Pharmaceuticals
- Orthofix
Stem Cell Therapy Market Insights:
The report forecasts that allogeneic stem cell therapy will remain the largest type segment over the forecast period, primarily due to its increasing application in treating cancer and the growing cases of cancer worldwide. Within the market, the musculoskeletal disorders application is expected to witness the highest growth over the forecast period, driven by the rising number of musculoskeletal disorders, such as orthopedic implant failure, cartilage repair, ligament repair, and carpal tunnel syndrome.
Geographically, North America is anticipated to remain the largest region over the forecast period, benefiting from its well-established healthcare infrastructure, advanced medical facilities, strong regulatory framework, and development and commercialization of innovative medical technologies.
Features of the Stem Cell Therapy Market
- Market Size Estimates: Stem cell therapy market size estimation in terms of value ($B)
- Trend And Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
- Segmentation Analysis: Stem cell therapy market size by various segments, such as type, cell source, application, and region
- Regional Analysis: Stem cell therapy market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
- Growth Opportunities: Analysis on growth opportunities in different types, applications, and regions for the stem cell therapy market.
- Strategic Analysis: This includes M&A, new type development, and competitive landscape for the stem cell therapy market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers the following 11 key questions
Q.1. What are some of the most promising, high-growth opportunities for the global stem cell therapy market by type (allogeneic stem cell therapy and autologous stem cell therapy), cell source (adipose tissue-derived MSCs (mesenchymal stem cells), bone marrow-derived MSCs, placental/umbilical cord-derived MSCs, and others), application (musculoskeletal disorders, wounds & injuries, cardiovascular diseases, surgeries, inflammatory & autoimmune diseases, neurological disorders, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or type substitution?
Q.11. What M&A activity did occur in the last five years and how did they impact the industry?
For more information about this report visit https://www.researchandmarkets.com/r/4urs1w
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900